New Classifications of Five Distinct “Sleep” Profi... ...
A Professional Overview of Hypertension ...
High-speed imaging tracks live brain cell activity...
Drug candidate slows motor neuron disease progress...
Drug candidate slows motor neuron disease progress...
Mark Cuban: A Master Disrupter for American Health...
Superbugs on your plate: How antimicrobial resistance spread...
June 13,2026
Can marijuana cause lung cancer?...
June 12,2026
Standard depression screening could be missing key symptoms ...
June 11,2026
More women are having babies later in life. How to improve y...
June 10,2026
For severe babesiosis, red blood cell exchange is associated...
June 09,2026
Cause or effect? Study answers question about gene linked wi...
June 08,2026
Category
Traditional Medicine
Q & A
Wellness
Drug Discovery
Technology & AI
Clinical Pearl Series
Breakthroughs
Immunology & Rheumatology
Reproduction
Hepatobiliary&Pancreas Surgery
Most Read
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and Sex

Blood Pressure Chart With Readings By Age and SexAverage Ranges Show Normal Pressure On the ArteriesBySheryl Huggins SalomonUpdated on April 21, 2023Medically reviewed byJeffre
Cardiovascular Diseases April 07,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals Advances Hair Loss Treatment with Phase 2 Study and $14M Funding

Pelage Pharmaceuticals has commenced dosing the first patients in its Phase 2a clinical trial for PP405, a novel topical treatment designed to reactivate dormant hair follicle stem cells.
Dermatology August 14,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs Mean

Blood Types: What Letters, Positive, and Negative Signs MeanWhat to Know About Your Blood TypeByNancy LeBrunPublished on September 15, 2023Medically reviewed byAnju Goel, MDYou
Oncology March 17,2024
Today's News
Eye Infections (Updated) | Clinical Medicine...
Announcement of the 2025 Nobel Prize in ...
Dr. Fauci among hundreds who've contract...
Why are young, healthy adults experienci...
Reprogramming Stem Cells Could Cure Type...
More News
Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp
Oncology December 19,2023
Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

Targeting cancer-supporting cells boosts immunotherapy in previously insensitive tumors

byInstitute of Cancer ResearchHuman breast cancer cells implanted in an experimental animal with two different tracers (red and blue) to investigate the interaction of tumour cells. Credit:&nbsp
Oncology December 19,2023
Promising Biomarkers for Early Detection of Prostate Cancer Risk Identified

Promising Biomarkers for Early Detection of Prostate Cancer Risk Identified

byColleen Fleisson August 18, 2023A cell metabolism process observed in males who have diabetes and metastatic prostate cancer holds the potential for future advancements in testing and tr
Oncology December 19,2023
Promising Biomarkers for Early Detection of Prostate Cancer Risk Identified

Promising Biomarkers for Early Detection of Prostate Cancer Risk Identified

byColleen Fleisson August 18, 2023A cell metabolism process observed in males who have diabetes and metastatic prostate cancer holds the potential for future advancements in testing and tr
Oncology December 19,2023
Immunotherapy Combo Boosts Survival in Metastatic Melanoma

Immunotherapy Combo Boosts Survival in Metastatic Melanoma

byColleen Fleisson August 19, 2023For patients diagnosed with advancedmetastatic melanomathat does not respond to the commonly utilized PD-1 inhibitors, immunotherapy drugs ipi
Oncology December 19,2023
Immunotherapy Combo Boosts Survival in Metastatic Melanoma

Immunotherapy Combo Boosts Survival in Metastatic Melanoma

byColleen Fleisson August 19, 2023For patients diagnosed with advancedmetastatic melanomathat does not respond to the commonly utilized PD-1 inhibitors, immunotherapy drugs ipi
Oncology December 19,2023
Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

byCancer Research UK| News30 January 2021People with an aggressive form of lung cancer that’s come back after treatment, leaving them with limited options, could live longer when treated w
Oncology December 19,2023
Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

Immunotherapy improves survival for people with aggressive, asbestos-linked lung cancer

byCancer Research UK| News30 January 2021People with an aggressive form of lung cancer that’s come back after treatment, leaving them with limited options, could live longer when treated w
Oncology December 19,2023
Advancing Against Melanoma With Microneedles Technology

Advancing Against Melanoma With Microneedles Technology

byColleen Fleisson August 22, 2023A novel strategy that combines a painless, minimally invasivemicroneedleplatform with the ability to absorb biomarker-rich fluid from the skin
Oncology December 19,2023
Advancing Against Melanoma With Microneedles Technology

Advancing Against Melanoma With Microneedles Technology

byColleen Fleisson August 22, 2023A novel strategy that combines a painless, minimally invasivemicroneedleplatform with the ability to absorb biomarker-rich fluid from the skin
Oncology December 19,2023
Targeting enzyme could alleviate muscle wasting for cancer patients

Targeting enzyme could alleviate muscle wasting for cancer patients

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainTargeting a specific enzyme in the muscle could help cancer patients preserve muscle mass and potentially p
Oncology December 19,2023
Targeting enzyme could alleviate muscle wasting for cancer patients

Targeting enzyme could alleviate muscle wasting for cancer patients

byUniversity of Texas Health Science Center at HoustonCredit: Pixabay/CC0 Public DomainTargeting a specific enzyme in the muscle could help cancer patients preserve muscle mass and potentially p
Oncology December 19,2023
Secrets of lung cancer spread found in patients’ blood and biopsies

Secrets of lung cancer spread found in patients’ blood and biopsies

byCancer Research UK| News7 October 2019Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a tri
Oncology December 19,2023
Secrets of lung cancer spread found in patients’ blood and biopsies

Secrets of lung cancer spread found in patients’ blood and biopsies

byCancer Research UK| News7 October 2019Early signs that a patient’s lung cancer may spread and become untreatable can be picked up in samples of their blood and tumour, according to a tri
Oncology December 19,2023
Targeted lung cancer drug shows promise in phase I/II clinical trial

Targeted lung cancer drug shows promise in phase I/II clinical trial

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainEarly trials of the targeted drug repotrectinib suggest that it could help treat patients with a certain t
Oncology December 19,2023
Targeted lung cancer drug shows promise in phase I/II clinical trial

Targeted lung cancer drug shows promise in phase I/II clinical trial

by European Organisation for Research and Treatment of CancerCredit: Pixabay/CC0 Public DomainEarly trials of the targeted drug repotrectinib suggest that it could help treat patients with a certain t
Oncology December 19,2023
More News
Week’s Top
Podcasts
... Preparing for a tough exam? A tough gym workout could help with your studies ... ... GOSH BRC Showcase 2025 - Genomic medicine ... ... Brain activity goes to extremes in soccer fans, neuroimaging reveals ...
FIND US ON
ABOUT
Who We Are
Contact Us
Editorial Team
Sitemap
Policy
Privacy Policy
Advertising Policy
Editorial Policy
Corrections Policy
Medical Disclaimer
Alliance
wmo.com
sleep.net
pharm.net
doctors.net
worldsleep.com